ACM
ABBV icon

Armbruster Capital Management’s AbbVie ABBV Stock Holding History

Armbruster Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Hold
2,181
– – 0.08% 82
2026
Q1 		$474K Buy
2,181
+29
+1% +$6.43K 0.08% 89
2025
Q4 		$492K Hold
2,152
– – 0.08% 89
2025
Q3 		$498K Hold
2,152
– – 0.08% 88
2025
Q2 		$399K Hold
2,152
– – 0.07% 98
2025
Q1 		$451K Hold
2,152
– – 0.09% 90
2024
Q4 		$382K Hold
2,152
– – 0.08% 97
2024
Q3 		$425K Buy
2,152
+132
+7% +$24.6K 0.08% 94
2024
Q2 		$346K Buy
2,020
+122
+6% +$20.2K 0.07% 95
2024
Q1 		$346K Hold
1,898
– – 0.07% 88
2023
Q4 		$294K Hold
1,898
– – 0.07% 91
2023
Q3 		$283K Hold
1,898
– – 0.07% 88
2023
Q2 		$256K Buy
1,898
+488
+35% +$71.6K 0.06% 95
2023
Q1 		$225K Hold
1,410
– – 0.06% 99
2022
Q4 		$228K Buy
+1,410
New +$216K 0.06% 98
2022
Q3 		– Sell
-1,410
Closed -$216K – 106
2022
Q2 		$216K Hold
1,410
– – 0.06% 108
2022
Q1 		$229K Buy
+1,410
New +$205K 0.06% 118
2018
Q2 		– Sell
-600
Closed -$57K – 70
2018
Q1 		$57K Sell
600
-74
-11% -$8.13K 0.03% 122
2017
Q4 		$65K Hold
674
– – 0.03% 113
2017
Q3 		$60K Sell
674
-354
-34% -$26.9K 0.03% 115
2017
Q2 		$75K Buy
1,028
+65
+7% +$4.37K 0.04% 107
2017
Q1 		$63K Sell
963
-100
-9% -$6.29K 0.04% 115
2016
Q4 		$67K Hold
1,063
– – 0.04% 112
2016
Q3 		$67K Hold
1,063
– – 0.04% 107
2016
Q2 		$66K Hold
1,063
– – 0.04% 107
2016
Q1 		$61K Hold
1,063
– – 0.04% 111
2015
Q4 		$63K Buy
+1,063
New +$61.2K 0.06% 114

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Armbruster Capital Management's ABBV Position: Q2 2026 in Review

Armbruster Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,181 shares worth $549K. The position accounts for 0.08% of the portfolio, ranked #82.

Armbruster Capital Management first reported a position in ABBV in Q4 2015 and has held it in 27 quarters since. 934 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Armbruster Capital Management held 2,181 shares of AbbVie worth $549K as of Q2 2026.
  • Armbruster Capital Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.08% of Armbruster Capital Management's portfolio in Q2 2026, its #82 holding.
  • Armbruster Capital Management first reported a position in AbbVie in Q4 2015 and has held it in 27 quarters since.
  • 934 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.